RxDoctor Payments Data

Jessica Mitchum, DO

Family Medicine · Moultrie, GANPI 1629510912

Payments from drug & device makers

$307in general payments, 2019–2025

Across 13 payments — averaging $23.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$60
  • Inspire Medical Systems, Inc.$48
  • Pfizer$46
  • AbbVie$46
  • Sanofi-aventis U.S. LLC$36
  • Lilly USA, LLC$35
  • plus $36 from 3 others

What the payments were for

  • Food & beverage$307100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$307 in reported general payments places this provider in the 35th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$33,874
Medicare patients
147
Services billed
497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide79$83,623
JardianceEmpagliflozin72$73,851
OzempicSemaglutide68$71,883
JanuviaSitagliptin Phosphate67$54,846
EliquisApixaban55$45,573
FarxigaDapagliflozin Propanediol29$27,042
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/717$17,459
LinzessLinaclotide15$13,294
TrulicityDulaglutide12$11,786
EntrestoSacubitril/Valsartan13$11,446
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,042
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$7,669
MyrbetriqMirabegron12$5,532
Tresiba Flextouch U-100Insulin Degludec11$5,179
SymbicortBudesonide/Formoterol Fumarate20$4,930

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$35$95,40891 claims
MerckJanuvia$13$54,84667 claims
PfizerEliquis$46$45,57355 claims
AbbVieLinzess$46$13,29415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Moultrie

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →